Elutia Inc
Veridion Score
Composite trend over time
Why is ELUT moving today?
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ELUT.
ELUT insider activity
Elutia Inc
No multi-insider buying cluster in the last 90 days
Net buying: $141K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 2026-06-21 | Mills C Randal | Insider | sell | $1.06 | 8,064 | 441,180 | $9K | SEC Form 4 |
| 2026-06-12 | 2026-06-10 | Williams Michelle LeRoux | Insider | sell | $1.04 | 4,269 | 118,052 | $4K | SEC Form 4 |
| 2026-06-12 | 2026-06-10 | Mills C Randal | Insider | sell | $1.04 | 9,718 | 426,771 | $10K | SEC Form 4 |
| 2026-06-12 | 2026-06-10 | Ferguson Matthew | Insider | sell | $1.04 | 4,485 | 480,082 | $5K | SEC Form 4 |
| 2026-03-12 | 2026-03-10 | Williams Michelle LeRoux | Insider | sell | $1.09 | 4,613 | 109,821 | $5K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 24 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moELUT contract awards, year to date.
Public federal awards linked to this ticker.
ELUT lobbying filings, year to date.
Registered lobbying filings matched to Elutia Inc.